14.08.2015 • NewsDede WillamsPeopleCovestro

Patrick Thomas Confirmed as Covestro CEO

Patrick Thomas and Frank H. Lutz have been confirmed as CEO and CFO respectively of the Bayer engineering plastics spin-off Covestro – the new name for Bayer MaterialScience (BMS) – starting Sept. 1.

Thomas has been CEO of BMS since 2007, while Lutz joined the company in 2014. Lutz, whose responsibilities on the BMS Executive Committee up to now have included administration and services along with the Europe, Africa and Middle East regions (EMEA / EEMEA), additionally will take over the function of labor director from Michael Bernhardt, who will leave the managing board to head an expanded Covestro Human Resources function.

Also joining the Covestro managing board will be Klaus Schäfer and Markus Steilemann. Schäfer, who has been on the BMS Executive Committee and Head of Industrial Operations since Jan. 1, 2015 will be Chief Industrial Operations Officer, covering production and technology.

Steilemann, who also has served on the Executive Committee, will initially be responsible for innovation and retain his function as head of the Polycarbonates business unit. From Jan. 1, 2016, he will additionally assume board responsibility for the Polyurethanes business unit. Joachim Wolff, currently responsible for Polyurethanes, will retire at the end of the year.

Daniel Meyer, presently head of Coatings, Adhesives and Specialties, will remain responsible for this business unit's operations. The new head of the Polycarbonates Business Unit will be announced at a later date.

"We are convinced we have made the right personnel decisions for the success of Covestro as a stand-alone company. Steered by this experienced management team, we intend to position Covestro as a leading company in the global arena and continue to grow dynamically in the future," said Richard Pott, chairman of the Bayer MaterialScience supervisory board.

Patrick Thomas added: "Going forward we aim to further strengthen customer proximity, innovative capability, efficiency and profitability – all of which are of crucial importance to Covestro.”

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.